The American Society of Health-System Pharmacists reports a shortage of injectable methyldopate. The explanation for this drug shortage lies in part in the voluntary recall of one lot of this product by the only maker, American Reagent. This drug is important for lowering high blood pressure in the short term before switching to an oral medication.
No comments:
Post a Comment